Frimley Health NHS Foundation Trust has revealed that a new aseptic production facility is going to be built soon at Wexham Park to support patients and staff while future-proofing cancer services at the hospital.
As an important part of the Trust's clinical infrastructure, this new facility will be a specialised, sterile, cleanroom environment.
The cleanroom will safeguard the location's ability to prepare specialist medicines for cancer treatments with very short shelf lives, such as chemotherapy, monoclonal antibodies, clinical trial medicines and compassionate‑use treatments.
Significantly, when open, the unit is expected to prepare more than 750 chemotherapy doses per month.
The Trust says that work on the project is progressing well, with teams currently ensuring that the technical foundations, ventilation and cleanroom designs of the 373 sqm unit are robust, compliant and fit for the future.
Alongside this design work, the Trust is also exploring modern building methods to deliver the new aseptic suite to the highest standards, while making best use of time and resources. All plans will also be carefully reviewed through the appropriate governance and steering processes.
The previous aseptic suite closed in September 2025, with the new, modern, Good Manufacturing Practices (GMP) compliant aseptic facility due to open in Spring 2027.